Edward Kendall assigned administration of his patent for isolating cortisone to Research Corporation. The Kendall-Hench Fund was established by a $100,000 grant from Merck and Co. and an allotment by Research Corporation of a portion of its income from patent rights in cortisone. The grants were designed to support research in endocrinology; however, the research area proved too narrow and the program lapsed. Drugs with corticosteroids are still used today to treat inflammatory, allergic and rheumatic diseases.
